Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
New findings suggest that NF-κB proteins regulate osteoclast differentiation and are potential therapeutic targets for treating osteoporosis (pages 1285—1289).
A novel anti-HIV strategy uses modified chemokines (intrakines), trapped within the endoplasmic reticulum, to block expression of HIV co-receptors on the host cell surface (pages 1110–1116).
A novel mechanism used by pathogenic mycobacteria to enter macrophages (in low complement environments) may provide a new therapeutic target for the treatment of tuberculosis.
Infusion of aging monkeys with growth hormone promotes proliferation of mammary epithelia, suggesting caution in treating the elderly with growth hormone supplements (pages 1141–1144).
Treating neurodegenerative disease with drugs that inhibit the activity of caspases (proteases that regulate apoptosis) is a therapeutic avenue beginning to be explored.